All Stories

  1. Preparing for the NASH Epidemic: A Call to Action

    Article • Diabetes Care, July 2021, American Diabetes Association

    Kenneth Cusi Cusi

  2. Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes

    Article • PLoS ONE, June 2021, PLOS

    Kenneth Cusi Cusi

  3. Prevalence of fatty liver and fibrosis in patients with T2DM in the USA.

    Article • Diabetes Care, December 2020, American Diabetes Association

    Kenneth Cusi Cusi

  4. Time to Include Nonalcoholic Steatohepatitis in the Management of Patients With Type 2 Diabetes

    Article • Diabetes Care, January 2020, American Diabetes Association

    Kenneth Cusi Cusi

  5. Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes

    Article • Diabetes Care, October 2019, American Diabetes Association

    Michael McPhaul, Kenneth Cusi Cusi

  6. Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes

    Article • Diabetes Care, May 2019, American Diabetes Association

    Kenneth Cusi Cusi

  7. Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial

    Article • Diabetes Care, May 2019, American Diabetes Association

    Kenneth Cusi Cusi

  8. Response to Comment on Bril et al. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. Diabetes Care 2018;41:187–192

    Article • Diabetes Care, August 2018, American Diabetes Association

    Kenneth Cusi Cusi

  9. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients

    Article • Diabetes Care, November 2017, American Diabetes Association

    Kenneth Cusi Cusi

  10. Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2017, Endocrine Society

    Kenneth Cusi Cusi

  11. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2016, Endocrine Society

    Michael McPhaul, Kenneth Cusi Cusi

  12. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2015, Endocrine Society

    Kenneth Cusi Cusi

  13. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease

    Article • Hepatology, November 2014, Wiley

    Kenneth Cusi Cusi

  14. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2014, Endocrine Society

    Kenneth Cusi Cusi

  15. The relationship between hepatitis C virus infection and diabetes: Time for a divorce?

    Article • Hepatology, August 2014, Wolters Kluwer Health

    Kenneth Cusi Cusi